Together, these data indicate the different roles of 53BP1-null versus the 53BP1 T334A mutation on regulation of DSB repair; furthermore, overcoming PARPi resistance through pharmacological targeting of the GSK3B-53BP1 axis requires functional 53BP1 in tumor cells. Here, GSK3B is linked to neoplasm.